nav1.8 sodium channels glaucoma Pages on BioPortfolio:

Table of Contents
Advances in the development of Cav2.2 (N-type) calcium channel blockers as ... for neuropathic pain · NaV1.8, a sodium channel target for the treatment of ...
http://www.bioportfolio.com/tableof.htm...

Results from other life science and pharmaceutical sites:

Patent selection
(or Nav1.8 sodium channel) antagonists for the treatment. of pain are claimed. ... glaucoma and cell proliferative disorders are claimed. The. Gardos Ca ...
http://www.biomedcentral.com/content/pdf/cd-720748.pdf...

Patent selection
(SNS; aka Nav1.8) sodium channels. Target indications. include pain, bowel disorders, ... treating cardiovascular disease, glaucoma, pain and benign ...
http://www.biomedcentral.com/content/pdf/cd-592926.pdf...

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.